What is the role of epsilon amino caproic acid (Amicar) in the treatment of pediatric von Willebrand disease (VWD)?

Updated: Feb 05, 2019
  • Author: Suchitra S Acharya, MD, MBBS; Chief Editor: Hassan M Yaish, MD  more...
  • Print
Answer

The following may be used in patients with von Willebrand disease (VWD):

  • Epsilon amino caproic acid (Amicar)

    • Inhibition of fibrinolysis

    • Useful in mucous membrane bleeding

    • Dose: 100 mg/kg/dose orally every 4-6 hours


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!